What Happened?
Tempe, AZ-based GT-Medical-Technologies Appointed Matt Likens as President and Chief Executive Officer
About the Company
Driven to raise the standard of care and improve the lives of patients with brain tumors, a team of brain tumor specialists formed GT Medical Technologies. FDA-cleared GammaTile Therapy is a Surgically Targeted Radiation Therapy (STaRT) for patients undergoing brain tumor removal surgery of newly diagnosed malignant and recurrent brain tumors. This "one-and-done" treatment eliminates the need for one to six weeks of daily external beam radiation therapy, allowing patients to go about their daily lives without the burden of additional trips to the hospital or clinic for ongoing treatment. Since its full market release in the United States in March 2020, GammaTile has been offered in more than 95 hospitals, with more centers being added each month.
About the Person
Matt Likens is President and Chief Executive Officer at GT Medical Technologies. Previously, Matt held various senior HR leadership roles in the industry.
Info Source
News
Short Profile